Equity-Based Compensation (Tables)

9 Months Ended

Sep. 28, 2012

Schedule Of Assumptions Used To Calculate Weighted Average Fair Value Of Stock Option Grants

The following table summarizes the fair value assumptions used to compute the weighted average fair value of stock option grants at the date of grant:

	9/28/12			9/30/11
Expected volatility		43.3	%		46.5	%
Risk-free interest rate		0.9	%		2.1	%
Expected term (in years)		5.3			5.3
Expected dividend yield		2.0	%		1.5	%

Schedule Of Stock Option Activity

The following is a summary of stock option activity during 2012 as of September 28, 2012:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in  millions)
Outstanding – beginning of year		20,719,482		$	7.68
Granted		2,102,207		$	3.95
Exercised		(138,665	)	$	0.48
Forfeited/expired		(5,180,890	)	$	7.06
Outstanding – end of period		17,502,134		$	7.48		3.8	$	0.1
Exercisable – end of period		14,868,901		$	7.94		2.9	$	0.1
Shares vested or expected to vest		17,305,651		$	7.51		3.7	$	0.1

Schedule Of Cash-Settled Stock Appreciation Rights Activity

The following is a summary of cash-settled SARs activity during 2012 as of September 28, 2012:

	Shares			Weighted Average Exercise Price
Outstanding – beginning of year		492,131		$	6.81
Granted		16,200		$	3.98
Forfeited/expired		(40,684	)	$	7.26
Outstanding – end of period		467,647		$	6.67

Schedule Of Restricted Stock Unit Activity

The following is a summary of restricted stock activity during 2012 as of September 28, 2012:

	Shares			Weighted Average Grant Date Fair Value
Non-vested – beginning of year		4,854,587		$	6.29
Granted		2,619,842		$	3.88
Vested		(2,390,007	)	$	6.09
Forfeited		(1,271,870	)	$	6.27
Non-vested – end of period		3,812,552		$	4.76

Schedule Of Performance Stock Unit Activity

The following is a summary of PSU activity during 2012 as of September 28, 2012:

	Shares			Weighted Average Grant Date Fair Value
Non-vested – beginning of year		2,269,410		$	5.51
Granted		1,963,478		$	3.98
Vested		(825,996	)	$	5.28
Forfeited		(1,716,260	)	$	4.96
Non-vested – end of period		1,690,632		$	4.40

Schedule Of Equity-Based Compensation Expense

The following table sets forth the total equity-based compensation expense resulting from stock options, SARs, restricted stock, and PSUs by line item on the Statements of Operations and Comprehensive Income (Loss):

	Third Quarter					Nine Months
	9/28/12			9/30/11		9/28/12			9/30/11
Cost of revenue – products	$	0.3		$	0.4	$	0.9		$	1.3
Cost of revenue – services		0.4			0.5		1.3			1.7
Research and development		1.0			2.3		4.2			7.9
Sales and marketing		0.6			1.0		2.3			3.7
General and administrative		3.1			2.1		7.1			7.3
Equity-based compensation expense before income taxes		5.4			6.3		15.8			21.9
Income tax benefit		(0.1	)		—		(0.3	)		(2.6	)
Total equity-based compensation expense after income taxes	$	5.3		$	6.3	$	15.5		$	19.3

Schedule Of Total Equity-Based Compensation Expense By Type

The following table sets forth the total equity-based compensation expense by type:

	Third Quarter				Nine Months
	9/28/12		9/30/11		9/28/12			9/30/11
Stock options	$	1.6	$	1.1	$	3.6		$	3.7
Cash-settled SARs		—		—		(0.1	)		(0.2	)
Restricted stock		3.3		3.8		9.1			13.6
Performance stock units		0.5		1.4		3.2			4.8
Total	$	5.4	$	6.3	$	15.8		$	21.9